D.E. Shaw & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
D.E. Shaw & Co's MRNA Position: Q3 2026 in Review
D.E. Shaw & Co increased its Moderna (MRNA) stake by 4.9% in Q3 2026, buying an estimated $131K and bringing the position to 26,170 shares worth $5.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2429.
D.E. Shaw & Co first reported a position in MRNA in Q2 2019 and has held it in 28 quarters since. The position peaked at $393M in Q2 2021. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- D.E. Shaw & Co held 26,170 shares of Moderna worth $5.04M as of Q3 2026.
- D.E. Shaw & Co bought 1,219 Moderna shares in Q3 2026, an estimated $131K.
- Moderna made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #2429 holding.
- D.E. Shaw & Co first reported a position in Moderna in Q2 2019 and has held it in 28 quarters since.
- D.E. Shaw & Co's Moderna position peaked at $393M in Q2 2021.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.